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Integration reactionHuman immunodeﬁciency virus (HIV) infection yields a high level of non-integrated viral DNA in
the infected cells and up to 99% of total viral DNA can be capable of transcription. This capability
of non-integrated viral DNA is reducing the efﬁcacy of anti-HIV drug development approaches that
solely focus on the integration reactions of viral replication. Using kinetic modeling, we show the
transient coordinated regulation of viral DNA production by retrovirus-encoded interacting
enzymes reverse transcriptase (RT) and integrase (IN), and thus we identify a possible mechanism
for reducing overall efﬁciency of viral replication. The results indicate that both INRT and INDNA
complexes and their formation rates affect RT processivity and thereby the viral DNA expression
level within the pre-integration complex.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Upon successful penetration into the cytoplasm of a target host
cell, replication of human immunodeﬁciency virus type 1 (HIV-1)
critically depends on two sequential processes: reverse transcrip-
tion of single-stranded viral RNA and integration of pro-viral
DNA into the infected cell genome. These fundamental early steps
of the replication process are regulated by two viral-encoded en-
zymes, reverse transcriptase (RT) and integrase (IN), respectively.
The HIV-1 RT is a heterodimer of p66 and p51 subunits. It can copy
both RNA and DNA templates and eventually synthesize double-
stranded DNA. The HIV-1 RT possesses three catalytic activities:
RNA-dependent DNA polymerase (RDDP), DNA-dependent DNA
polymerase (DDDP), and ribonuclease H [1]. Subsequently, RT-
synthesized DNA becomes an integral component of a large nucle-
oprotein particle, termed the pre-integration complex (PIC). The
PIC-associated proteins include HIV-1 matrix, Vpr, RT, and IN.
These also include cellular components such as lens epithelium de-
rived growth factor p75, barrier to auto-integration factor, and the
high mobility group I(Y) protein [2]. The viral replication process is
initiated with the transportation of PIC into the cell nucleus and
the integration of viral DNA into the host chromosomal DNA,
which is catalyzed by IN. The presence of IN is essential for the sta-bilization of the pre-integration complex and for the nuclear im-
port of pro-viral DNA. These non-catalytic activities of IN are also
crucial for the viral replication process [2].
The pre-integration complex (PIC) that includes several viral
proteins as well as cellular components provides an optimal envi-
ronment for the activity of both reverse transcriptase (RT) and
intergrase (IN) enzymes through various molecular interactions
[3]. There have been several pieces of evidence suggesting the exis-
tence of direct and indirect interactions between HIV-1 IN and RT
[4,5]. Direct physical interactions occur as RT binds to the C-
terminal domain (CTD) of IN [6,7]. Puriﬁed HIV-1 IN and RT have
been observed to physically interact in co-immunoprecipitation,
glutathione S-transferase-based pulldown, and surface plasmon
resonance (SPR) experiments. Assays with IN deletion constructs
showed that the IN CTD is both necessary and sufﬁcient for RT–
IN association. Such contacts are accompanied by the inhibition
of catalytic activities of IN by HIV-1 RT. Indirect interaction be-
tween IN and RT occurs as the product of RT-catalyzed reactions
binds to the IN protein. In vitro studies with puriﬁed IN and RT
have shown that HIV-1 IN can indirectly stimulate both the initia-
tion and elongation modes of RT-catalyzed reverse transcription by
enhancing RT processivity [7]. However, how these two key viral
enzymes coordinate viral DNA production by affecting each other
activity is still poorly understood.
In the early steps of HIV replication, reverse transcription of
viral RNA and subsequent integration of viral DNA into the host
Fig. 1. A schematic representation of the model for direct (dotted line) and indirect
(solid line) interactions between HIV-1 IN and RT: RNA-dependent- and DNA-
dependent DNA polymerase activities of RT are modeled with Michaelis–Menten
kinetics, which are also inﬂuenced intrinsically by linear dissociation and re-
association rates of RT with DNA/RNA and DNA/DNA primer/template substrates.
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DNA levels can reach 99% of total viral DNA at the asymptomatic
phase of infection [9]. This non-integrated DNA has full capacity
to synthesize all classes of viral transcripts, both spliced and
non-spliced, prior to integration [8,10,11]. For example, translation
of early viral gene products such as Nef [12], Tat [13], and Rev [8]
from viral mRNA of non-integrated DNA origin has been well doc-
umented. Such transcription ability and high availability of non-
integrated DNA in the infected cell is reducing the efﬁcacy of cur-
rent anti-HIV drug development approaches that solely focus on
the integration reactions of viral replication. In this paper, we dem-
onstrate how direct and indirect mode of interactions between RT
and IN affect viral DNA production and then quantify the relation-
ship between viral DNA and DNA-free IN expression level within
the pre-integration complex.
2. Methods
In reverse transcription, single-stranded viral RNA is tran-
scribed into double-stranded DNA (dsDNA) through the catalytic
activities of RT encoded by the HIV-1 pol gene. The kinetic mecha-
nisms of polymerization catalyzed by the HIV-1 RT underpin pri-
mer/template binding to RT and subsequent nucleotide binding
to this complex. Pre-steady-state kinetic analyses suggest that
after the initial binding of the nucleotide to the RT-primer/tem-
plate complex, an isomerization is induced, leading to a tight ter-
nary complex. This isomerization represents the rate-limiting
step of nucleotide incorporation. Single nucleotide incorporation
experiments show a rapid burst of product formation that is suc-
ceeded by a slower approximate linear phase [14–16]. The linear
phase observed in these experiments is due to dissociation of the
enzyme/substrate complex prior to incorporation of dNTP and rep-
resents the rate-limiting step for the polymerase reactions. We
model these kinetic steps starting from the formation of the RT-
substrate complex. As the burst rate of product formation strictly
depends on the nature of primer/template complexes, we describe
the RT-catalyzed reaction rates of the viral DNA formation by dif-
ferent kinetic parameters for the DNA/DNA and DNA/RNA pri-
mer/template, which are also affected by different disassociation
and re-association rates of RT with these two substrates. The RT
catalysis is assumed to be irreversible (RTDNA/DNA? dsDNA,
RTDNA/RNA? dsDNA) and competitive binding of dsDNA to RT
has been neglected. The RT is assumed to be present excessively,
so that the re-association and dissociation reactions follow linear
kinetics. The RT-catalyzed reactions are modeled by using the irre-
versible Michaelis–Menten equation.
The integrase enzyme, a 32 kDa protein with 288-amino acid
residues encoded by HIV-1, binds to RT-synthesized DNA. The
presence of an intact integrase is required for the stabilization of
pre-integration complex and their transport into the cell nucleus.
These non-catalytic functions of IN are indirectly controlling the
synthesis of viral DNA. The integrase-mediated interaction by di-
rect RT binding has been elucidated and analyzed by Herschhorn
et al. [5] using the surface plasmon resonance technology that
monitors direct protein–protein interactions. To construct a kinetic
model of IN and RT interactions, a number of speciﬁc assumptions
are introduced, which are either to simplify underlying complexi-
ties or to explain speciﬁc interaction characteristics inﬂuencing re-
verse transcription and associated viral DNA production. In
addition to above mentioned kinetic assumptions, following are
the list of basic, structural model assumptions for easy reference:
(1) The pre-integration complex (PIC) includes various viral pro-
teins such as matrix (MA), nucleocapsid (NCp7), integrase (IN),
reverse transcriptase (RT), Vif, and Tat [17,18] and cellular compo-
nents such as HMG I(Y) and barrier to autointegration factor (BAF)[19,20]. For PIC formation, stabilization, and subsequent nuclear
import, multiple intra- and intermolecular interactions and molec-
ular rearrangements are required at different stages. To make the
model simple and analytically tractable, we assume RT and IN
interactions independent of other PIC components. However, the
model results can be improved further by incorporating the effects
of other viral and cellular components of PIC through their molec-
ular interactions with RT/IN and associated complexes.
(2) The reverse transcriptase (RT) enzyme possesses polymerase
activities on both RNA and DNA templates and the ribonuclease H
(RNase H) activity. RNase H degrades the RNA strand of RNA/DNA
hybrids. As ploymerization proceeds, RNase H activity degrades
RNA of the RNA/DNA replication intermediates [21]. Although
RNase H activity and its interplay with polymerase activity have
well-documented [22,23], it remains unclear how RT–RNase H dis-
tinguishes between RNA/DNA hybrid and the structurally similar
RNA/RNA homoduplex. For model simpliﬁcation and speciﬁc func-
tional characterizations of IN–RT interactions, we have not
involved the documented interplay between RT-polymerase and
RNase H activities. However, when kinetic mechanisms of the
interplay between RT–RNase H activity and IN–RT interactions
are better understood, this part of the model can be easily
improved.
The schematic diagram of the model is represented in Fig. 1 and
associated rate equations are described by a system of ordinary dif-
ferential equations. The kinetic parameters used in the numerical
simulations are listed in Table 1:
d½RT=dt ¼ !kd;RTIN ½RTINka;RTIN ½RT½IN
Direct interaction
þkd;RTDNA=RNA½RT  DNA=RNA
 ka;RTDNA=RNA½RT½DNA=RNA þ kd;RTDNA=DNA½RT
 DNA=DNA  ka;RTDNA=DNA½RT½DNA=DNA
d½IN=dt ¼ !kd;RTIN ½RTINka;RTIN ½RT½IN
Direct interaction
þkd;INDNA½IN  DNA  ka;INDNA½IN
 ½vDNA
Table 1
Kinetic parameters used for numerical simulation.
Parameter (unit) Description Model input References
ka,INDNA (mol1s1) Rate constant of IN and DNA association 0.012  109 [29]
ka,RTDNA/RNA (mol1 s1) Rate constant of RT and DNA/RNA association 4  106 [30]
ka,RTDNA/DNA (mol1 s1) Rate constant of RT and DNA/DNA association 4.0  106 [30]
kd,RTIN (s1) Rate constant of RT and IN dissociation 3.30  102 [5]
kd,INDNA (s1) Rate constant of IN and DNA dissociation 21  109 [29]
kd,RTDNA/RNA (s1) Rate constant of RT and DNA/RNA dissociation 0.04 [30]
kd,RTDNA/DNA (s1) Rate constant of RT and DNA/DNA dissociation 0.13 [31]
kcat,RT-RNA (s1) kcat for RNA-dependent DNA polymerase activity of RT 0.04 [30]
kcat,RT-DNA (s1) kcat for DNA-dependent DNA polymerase activity of RT 0.081 [31]
kM,RT-RNA (mol/l) kM for RNA-dependent DNA polymerase activity of RT 0.0065  109 [31]
kM,RT-DNA (mol/l) kM for DNA-dependent DNA polymerase activity of RT 0.60  109 [31]
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þ ½RTkcat;RTRNA½RT  DNA=RNA=ðkM;RTRNA þ ½RT
 DNA=RNAÞ þ ½RTkcat;RTDNA½RT
 DNA=DNA=ðkM;RTDNA þ ½RT  DNA=DNAÞ
d½RT  DNA=RNA=dt ¼ ka;RTDNA=RNA½RT½DNA=RNA  kd;RTDNA=RNA½RT
 DNA=RNA  ½RTkcat;RTRNA½RT
 DNA=RNA=ðkM;RTRNA þ ½RT  DNA=RNAÞ
d½RT  DNA=DNA=dt ¼ ka;RTDNA=DNA½RT½DNA=DNA
 kd;RTDNA=DNA½RT  DNA=DNA
 ½RTkcat;RTDNA½RT  DNA=DNA=ðkM;RTDNA
þ ½RT  DNA=DNAÞ
d½IN  DNA=dt ¼ ka;INDNA½IN½vDNA  kd;INDNA½IN  DNA
d½RT  IN=dt ¼ ka;RTIN½IN½RT  kd;RTIN½RT  IN
Numerical simulation of the model solutions has been carried
out in the freely available software WINPP. Standard Runge–Kutta
method of the fourth order is implemented for the computation
that runs for the deﬁned 200 time-steps with delta T, 0.05. Series
of simulation has been run with different IN/RT ratios: (a) equal
expression levels, (b) upto ﬁvefold up-regulation of IN, RT, and
both from the equimolecular level, and (c) upto ﬁvefold down-reg-
ulation of IN, RT, and both from the equimolecular level.
3. Results and discussion
The formation and stabilization of the pre-integration complex
(PIC), which is a crucial step for the subsequent integration of viral
DNA into the host cell genome, involves direct and indirect modes
of interaction between HIV-1 RT and IN (Fig. 1). The viral DNA pres-
ent in PIC serves as the donor DNA for the subsequent integration
process catalyzed by IN. It can also serve as the undesirable target
DNA for self-integration as all potential integration components
are present in the PIC, which is known as auto-integration process.
The direct physical interaction of binding RT with HIV-1 IN is
known to prevent auto-integration before the viral DNA reaches
the host chromosome, and is thus biologically signiﬁcant [5]. Indi-
rect interactions inevitably occur, as the RT-synthesized DNA
serves as the substrate for IN activities. However, their relative bio-
logical signiﬁcance remains unknown. Since the RT/IN molecular
ratios in virions and in the infected cell are expected to be equimo-
lar, we have perturbed this ratio in order to examine how it jointly
affects viral DNA synthesis within PIC, and then calculated the
steady-state viral DNA levels that are regulated by direct and indi-
rect interactions between HIV-1 IN and RT.The modes of interaction between integrase and reverse trans-
criptase and its biological implication are known to be dependent
on their afﬁnities to bind with other cellular and viral components
of PIC [24]. In vitro studies on inhibition of IN activities by HIV-1 RT
are merely focused on the direct physical interaction via IN–RT
complex formation, whereas an indirect mode of interaction has
been shown to stimulate both the initiation and elongation modes
of RT-catalyzed reverse transcription by enhancing RT processivity.
We therefore analyzed the levels of RT-synthesized DNA with the
combinedmodes of interaction, revealing a mechanism of pro-viral
DNA regulation within PIC.
In Fig. 2, the distribution pattern of viral DNA concentration
over the time course of RT-mediated synthesis has been simulated
with the changes in the RT and IN expression levels from the equi-
molecular level. It shows a unimodal distribution of viral DNA over
the time course of DNA synthesis. While the IN expression level
has decreased below the RT expression level, DNA synthesis is
up-regulated and prolonged with a higher initial peak, whereas
the increased IN expression level has exerted the complete oppo-
site effect with a lower initial peak (Fig. 2A). In contrast, parallel
up- and down-regulations of RT have proportional effects on the
respective increased and decreased viral DNA production levels,
with relatively higher initial peaks and curtailed period of time
for DNA synthesis (Fig. 2B). These two results suggest an inverse
relationship between the mode of viral DNA regulation by the dis-
tinct expression levels of IN and RT; with increased (decreased) IN,
viral DNA synthesis has down (up)-regulated, whereas RT exerts
completely opposite effects. We have thus investigated their rela-
tive effects while both expression levels change simultaneously.
When the expression levels of IN and RT are decreased unequally,
slightly below the equimolar level, viral DNA levels signiﬁcantly
decrease initially, however, later increase with the elongated peri-
od of DNA synthesis (Fig. 2C). The opposite occurs when IN and RT
expression levels are increased unequally (Fig. 2D). The simulated
results are summarized in Table 2.
In order to measure the relative effect of direct and indirect
modes of interaction on the viral DNA synthesis, an analytical
expression has been derived from the steady-state of viral DNA
synthesis. Assuming excess substrates for the RT, it simpliﬁes to:
½vDNA ¼ kd;INDNA
ka;INDNA
½IN DNAþ Vmax;RTRNAþVmax;RTDNAð Þ
 
1
½IN ð1Þ
The maximal velocity Vmax equals the catalytic rate constant
(kcat) multiplied by the total enzyme concentration. At the satura-
tion level, Eq. (1) simpliﬁes to:
½vDNA ¼ ½IN  DNA þ Vmax;RTRNA þ Vmax;RTDNAð Þ½  1½IN ð2Þ
The ﬁrst term on the right hand side represents a quantitative
measure of the indirect effect of IN on RT-catalyzed DNA synthesis
through the formation of an INDNA complex. The second term
Fig. 2. Simulated levels of viral DNA production over the time course of RT-catalyzed DNA synthesis: when IN and RT have equal expression levels (black line, 0.1  102 mol/
l) with the initial cellular concentration of other model variables, 0.1  109 mol/l, up to ﬁvefold up-regulation from the equimolecular level (blue line), up to ﬁvefold down-
regulation from the equimolecular level (red line), IN and RT are inversely regulated (purple line). (A) inﬂuence of IN expression variation with constant RT expression; (B)
inﬂuence of RT expression variation with constant IN expression level; (C) effect of down-regulation of both IN and RT; (D) effect of up-regulation of both IN and RT; (E) effect
of RT-up and IN-down regulation; (F) effect of RT-down- and IN-up regulation.
Table 2
Simulated relative effects of IN–RT interactions on viral DNA synthesis (up- and down-regulations of vDNA are represented relative to its distribution over time when both IN and
RT are equally expressed).
Integrase (IN) expression level Reverse transcriptase (RT) expression level vDNA distribution over the time course of RT-catalyzed DNA synthesis
Constant and equal Unimodal distribution
IN " Constant vDNA ;
IN ; Constant vDNA "
Constant RT " vDNA "
Constant RT ; vDNA ;
IN " RT " vDNA " then vDNA ;
IN ; RT ; vDNA ; then vDNA "
IN ; RT " vDNA "
IN " RT ; vDNA ;
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the DNA synthesis through the formation of a RTIN complex. This
analytical expression describes a quantitative relationship be-
tween DNA-free IN and RT-synthesized DNA levels within a stable
PIC. To get qualitative insights, we have plotted [vDNA] against [1/
IN] with only the direct and the combined mode of interactions be-
tween IN and RT. It showed that while the direct mode of interac-tion failed to down-regulate DNA synthesis, the indirect
interaction provides a negative feedback that down-regulates the
DNA synthesis and consequently its expression level (Fig. 3).
The integration of viral DNA into the host genome sequentially
follows two key reactions catalyzed by the viral protein, integrase
(IN). The ﬁrst key reaction known as 30-end processing is the cleav-
age of dinucleotides from each 30-end of the viral DNA LTR site
Fig. 3. Coordinated regulation of viral DNA synthesis by HIV-1 encoded IN and RT
enzymes: simulated effect of direct (red line) and combined (black) mode of
interaction. The indirect interaction provides a negative feedback that down-
regulates the DNA synthesis and consequently its expression level.
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cessed DNA end is inserted into the host cell DNA. In vivo, the tight
binding of IN to viral DNA remains associated after 30-processing
long enough for subsequent integration. To inhibit IN-catalyzed
integration reactions, the anti-HIV drug development strategies
primarily focus on inhibitors of strand transfer reactions targeting
the preformed complex of IN and viral DNA [26]. The great stability
of the IN–DNA complex and its presence in the cell throughout
most of the pre-integration steps make this complex the most suit-
able target. One such compound, Raltegravir, was approved for
clinical use in 2007 as the ﬁrst antiretroviral drug (ARV) targeting
the viral integrase (IN) [27]. This inhibitor acts by binding to the
IN–viral DNA complex, close to the 30-end of the donor DNA and
thereby selectively blocking the strand transfer step. Based on
the results derived from our model (Eq. (2)), we indicate here that
besides targeting the IN–viral DNA complex that inhibits the
strand transfer reaction, targeting the IN–RT complex that inhibits
the RT processivity as well as IN activities can reduce the overall
efﬁciency of viral replication, as both the INDNA and INRT com-
plex formation with excess IN transiently reduce viral DNA produc-
tion. This parallels the ﬁndings of Zhu et al. [28] that the mutation
of an N-terminal Cys residue of HIV-1 IN (C130S) disrupts the
interaction between IN and RT, and abolishes the ability of the
virus to initiate endogenous reverse transcription.
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